SCHEMBL4757596

SCHEMBL4757596

CC(=O)NCC(=O)N1CCC([C]=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAP Q12884 2/20 0.44
DPP4 P27487 1/20 0.44
PREP P48147 1/20 0.44
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 6/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
TGM2 P21980 1/20 0.34
JUN P05412 1/20 0.34
CDK2 P24941 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12436977 0.79 FAP (0.46) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL14115757 0.79 GNAI3 (0.49) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL24272052 0.78 L3MBTL1 (0.47) FAPDPP4PREPALDH1A1MEN1
SCHEMBL8342117 0.78 FAP (0.45) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL4757597 0.77 FAP (0.44) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL10274507 0.77 L3MBTL3 (0.46) FAPDPP4PREPALDH1A1MEN1
SCHEMBL17642627 0.77 FAP (0.44) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL3950282 0.76 DPP4 (0.49) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL17737713 0.76 DPP4 (0.49) FAPDPP4PREPNPSR1ALDH1A1
SCHEMBL23573320 0.75 EPHX2 (0.45) FAPDPP4PREPALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO claimed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US claimed
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO disclosed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275085-A1 Piperidine derivative and use thereof TACR2, TACR1, PRLHR FAP 3998/4885DPP4 1785/4885PREP 909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.